New drug hope for myelofibrosis patients with low platelets
NCT ID NCT05980806
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This Phase 2 trial tests the drug selinexor in people with myelofibrosis who have not taken JAK inhibitors and have low to normal platelet counts. The main goal is to see if selinexor can shrink the spleen by at least 35% after 24 weeks. Researchers will also check if it improves symptoms and monitor for side effects. About 58 participants will receive either selinexor or a standard JAK inhibitor for comparison.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- selinexor (also known as KPT-330)
- What this could lead to
- If successful, selinexor could offer a new treatment option for myelofibrosis patients with low platelet counts who cannot use standard JAK inhibitors.
- What could go wrong
- This is an early Phase 2 study with only 58 participants, so results may not apply to everyone. Selinexor may cause side effects like nausea, fatigue, or low blood counts.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MILD THROMBOCYTOPENIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
"Georgios Papanikolaou" General Hospital of Thessaloniki
RECRUITINGThessaloniki, Central Macedonia, 57010, Greece
-
AIDPORT
RECRUITINGSkórzewo, 30 60-185, Poland
-
Aarhus Universitetshospital
RECRUITINGAarhus N, Central Jutland, 8200, Denmark
-
Azienda Ospedaliero-Universitaria Citta della Salute e della Scienza di Torino
RECRUITINGTorino, Turin, 10126, Italy
-
Azienda Ospedaliero-Universitaria Maggiore della Carità di Novara
RECRUITINGNovara, 28100, Italy
-
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda
RECRUITINGMilan, 20162, Italy
-
CHU Tours, Hôpital Bretonneau Service d'Hématologie thérapie cellulaire
RECRUITINGTours, Indre-et-Loire, 37044, France
-
Carmel Medical Center
RECRUITINGHaifa, 3436212, Israel
-
Centre Hospitalier Lyon-Sud
RECRUITINGPierre-Bénite, Auvergne-Rhône-Alpes, 69495, France
-
Centre Hospitalier Universitaire d'Angers
RECRUITINGAngers, Pays de la Loire Region, 49 933, France
-
Centre Hospitalier Universitaire de Saint-Etienne
RECRUITINGSaint-Priest-en-Jarez, 42270, France
-
Chu De Nîmes - Institut De Cancérologie Du Gard
RECRUITINGNîmes, Occitanie, 30029, France
-
City of Hope - Duarte Main Site
RECRUITINGDuarte, California, 91010, United States
-
Cleveland Clinic
RECRUITINGCleveland, Ohio, 44195, United States
-
Coltea - Spital Clinic
RECRUITINGBucharest, 30167, Romania
-
Complejo Asistencial Universitario de Salamanca - Hospital Clínico
RECRUITINGSalamanca, 37007, Spain
-
Duke University
RECRUITINGDurham, North Carolina, 27705, United States
-
Fakultní nemocnice Olomouc
RECRUITINGOlomouc, 779 00, Czechia
-
Fondazione IRCCS Cà Granda - Ospedale Maggiore Policlinico
RECRUITINGMilan, Milan, 20122, Italy
-
Fondazione IRCCS Policlinico San Matteo
RECRUITINGPavia, 27100, Italy
-
Guy's and Saint Thomas' NHS Foundation Trust
RECRUITINGLondon, SE1 9RT, United Kingdom
-
Hematology Division, Mauriziano Hospital, University of Turin
RECRUITINGOrbassano, Torino, 10043, Italy
-
Hospital Clínico Universitario Virgen de la Arrixaca
RECRUITINGEl Palmar, Murcia, 30120, Spain
-
Hospital Clínico Universitario de Valencia
RECRUITINGValencia, 46010, Spain
-
Hospital Germans Trias i Pujol
RECRUITINGBadalona, Barcelona, 8916, Spain
-
Hospital San Pedro de Alcantara
RECRUITINGCáceres, 10003, Spain
-
Hospital Universitario Central de Asturias
RECRUITINGOviedo, Principality of Asturias, 33011, Spain
-
Hospital Universitario de Gran Canaria Doctor Negrin
RECRUITINGLas Palmas de Gran Canaria, 35010, Spain
-
Huntsman Cancer Institute
RECRUITINGSalt Lake City, Utah, 84112, United States
-
Hôpital Cochin
RECRUITINGParis, 75014, France
-
Hôpital Saint-Louis
RECRUITINGParis, 75010, France
-
IRCCS Azienda Ospedaliero-Universitaria di Bologna
RECRUITINGBologna, 40138, Italy
-
IRCCS Ospedale Policlinico San Martino
RECRUITINGGenova, 16132, Italy
-
Institut Bergonié
RECRUITINGBordeaux, Aquitaine, 33000, France
-
Institut Català d'Oncologia Girona
RECRUITINGGirona, 17007, Spain
-
Institutul Regional de Oncologie Iasi
RECRUITINGIași, 700483, Romania
-
Istituto Europeo di Oncologia
RECRUITINGMilan, 20141, Italy
-
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori - IRST
RECRUITINGMeldola, Italy
-
Kaohsiung Medical University Chung-Ho Memorial Hospital
RECRUITINGKaohsiung City, 807, Taiwan
-
Laiko General Hospital of Athens
RECRUITINGAthens, Attica, 11527, Greece
-
MD Anderson
RECRUITINGHouston, Texas, 77030, United States
-
Marien Hospital Düsseldorf
RECRUITINGDüsseldorf, 40479, Germany
-
Maryland Oncology Hematology - Independent of SCRI/ US Oncology
RECRUITINGColumbia, Maryland, 21044, United States
-
Medicover Clinical Integrated Systems Sp. z o.o.
RECRUITINGTorun, 87-100, Poland
-
National Taiwan University Hospital
RECRUITINGTaipei, 100, Taiwan
-
Pusan National University Hospital
RECRUITINGBusan, 49241, South Korea
-
Rambam Health Care Campus
RECRUITINGHaifa, 3109601, Israel
-
Research Institute of the McGill University Health Centre
RECRUITINGMontreal, Quebec, H4A 3J1, Canada
-
Samodzielny Publiczny Szpital Kliniczny Nr 4 w Lublinie
RECRUITINGLublin, 20-954, Poland
-
Semmelweis Egyetem
RECRUITINGBudapest, 1088, Hungary
-
Seoul National University Hospital
RECRUITINGSeoul, Seoul Teugbyeolsi, 3080, South Korea
-
Seoul St. Mary's Hospital, The Catholic University of Korea
RECRUITINGSeocho, Seoul, 6591, South Korea
-
Severance Hospital
RECRUITINGSeoul, Seoul Teugbyeolsi, 3722, South Korea
-
Spaarne Gasthuis
RECRUITINGHoofddorp, 2134 TM, Netherlands
-
Specialized Hospital for Active Treatment of Hematological Diseases - EAD Sofia
RECRUITINGSofia, 1756, Bulgaria
-
Spitalul Filantropia - Craiova
RECRUITINGCraiova, 200143, Romania
-
Taoyuan Chang Gung Memorial Hospital
RECRUITINGTaoyuan, 333, Taiwan
-
Tel Aviv Sourasky Medical Center
RECRUITINGTel Aviv, Tel Aviv, 6423906, Israel
-
UZ Gent
RECRUITINGGhent, 9000, Belgium
-
UZ Leuven - Campus Gasthuisberg
RECRUITINGLeuven, 3000, Belgium
-
University General Hospital Attikon
RECRUITINGAthens, Attica, 124 62, Greece
-
University General Hospital of Ioannina, Hematology Department
RECRUITINGIoannina, Epirus, 45500, Greece
-
University General Hospital of Larissa, Hematology Department
RECRUITINGLarissa, Thessaly, 41110, Greece
-
University Hospital Jena
RECRUITINGJena, 7747, Germany
-
University Hospital Sv.Ivan Rilski - Sofia
RECRUITINGSofia, 1431, Bulgaria
-
University Multiprofile Hospital for Active Treatment - Prof. Dr. Stoyan Kirkovich AD Department of Clinical Hematology
RECRUITINGStara Zagora, 6003, Bulgaria
-
University Multiprofile Hospital for Active Treatment Aleksandrovska
RECRUITINGSofia, 1431, Bulgaria
-
University Multiprofile Hospital for Active Treatment Sveti George - Base 1
RECRUITINGPlovdiv, 4002, Bulgaria
-
Università Campus Bio-Medico di Roma
RECRUITINGRome, 128, Italy
-
Weill Cornell Medicine NewYork-Presbyterian
RECRUITINGNew York, New York, 10021, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new daily pill shrink the spleen and ease myelofibrosis symptoms?
- Can a new pill tame myelofibrosis?
- MRI as a window into bone marrow disease: a new biomarker test?
- Can a menin inhibitor tame myelofibrosis when standard drugs fall short?
- Can a drug free myelofibrosis patients from frequent blood transfusions?
- Heart safety check for new myelofibrosis drug in healthy volunteers